It is in Phase 3 investigational trials as a "next generation" weight loss medication with potentially fewer side effects compared to single-receptor predecessors like Semaglutide or dual receptor meds like Tirzepatide
IGF-1 LR3 is the primary protein involved in responses of cells to growth hormone (GH): that is, IGF-I is produced in response to GH and then induces cellular activities
What you should not do is run it 7 days/week indefinitely the receptor desensitization issue still applies
Bioorg Med Chem 19:60066014 Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guig R, Gladyshev VN (2003) Characterization of mammalian selenoproteomes
Our expert team designs personalized plans that go beyond dieting, integrating peptides into proven rapid weight loss programs tailored to your metabolism
Months 4-6: Anti-aging effects accumulate